Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892269780> ?p ?o ?g. }
- W2892269780 endingPage "1293" @default.
- W2892269780 startingPage "1286" @default.
- W2892269780 abstract "Xanthine oxidase (XO) is an interesting target for the synergic treatment of several diseases. Coumarin scaffold plays an important role in the design of efficient and potent inhibitors. In the current work, twenty 3-arylcoumarins and eight 3-heteroarylcoumarins were evaluated for their ability to inhibit XO. Among all the candidates, 5,7-dihydroxy-3-(3'-hydroxyphenyl)coumarin (compound 20) proved to be the best inhibitor with an IC50 of 2.13 μM, being 7-fold better than the reference compound, allopurinol (IC50 = 14.75 μM). To deeply understand the potential of this compound, the inhibition mode was also evaluated. Compound 20 showed an uncompetitive profile of inhibition. Molecular docking studies were carried out to analyze the interaction of compound 20 with the studied enzyme. The binding mode involving residues different from the catalytic site of the binding pocket, is compatible to the observed uncompetitive inhibition. Compound 20 was not cytotoxic at its IC50 value, as demonstrated by the viability of 99.1% in 3 T3 cells. Furthermore, pharmacokinetics and physicochemical properties were also calculated, which corroborated with the potential of the studied compounds as promising XO inhibitors." @default.
- W2892269780 created "2018-09-27" @default.
- W2892269780 creator A5015967784 @default.
- W2892269780 creator A5016579839 @default.
- W2892269780 creator A5022825134 @default.
- W2892269780 creator A5035798686 @default.
- W2892269780 creator A5040020657 @default.
- W2892269780 creator A5064016293 @default.
- W2892269780 creator A5064488322 @default.
- W2892269780 creator A5070602119 @default.
- W2892269780 creator A5073819549 @default.
- W2892269780 creator A5089935956 @default.
- W2892269780 date "2018-12-01" @default.
- W2892269780 modified "2023-10-06" @default.
- W2892269780 title "Coumarin derivatives as promising xanthine oxidase inhibitors" @default.
- W2892269780 cites W1441625760 @default.
- W2892269780 cites W1485349342 @default.
- W2892269780 cites W1507625951 @default.
- W2892269780 cites W1952940373 @default.
- W2892269780 cites W1965092590 @default.
- W2892269780 cites W1967340332 @default.
- W2892269780 cites W1970424799 @default.
- W2892269780 cites W1985889136 @default.
- W2892269780 cites W1987268792 @default.
- W2892269780 cites W1999436574 @default.
- W2892269780 cites W2003333173 @default.
- W2892269780 cites W2003593084 @default.
- W2892269780 cites W2004691151 @default.
- W2892269780 cites W2005686655 @default.
- W2892269780 cites W2008729446 @default.
- W2892269780 cites W2008883569 @default.
- W2892269780 cites W2014886061 @default.
- W2892269780 cites W2019957422 @default.
- W2892269780 cites W2024984581 @default.
- W2892269780 cites W2033495141 @default.
- W2892269780 cites W2038250774 @default.
- W2892269780 cites W2050548281 @default.
- W2892269780 cites W2058364660 @default.
- W2892269780 cites W2064999593 @default.
- W2892269780 cites W2087801233 @default.
- W2892269780 cites W2098006500 @default.
- W2892269780 cites W2106403351 @default.
- W2892269780 cites W2115741804 @default.
- W2892269780 cites W2120114502 @default.
- W2892269780 cites W2136310944 @default.
- W2892269780 cites W2144198700 @default.
- W2892269780 cites W2144308706 @default.
- W2892269780 cites W2148847926 @default.
- W2892269780 cites W2149863634 @default.
- W2892269780 cites W2168228932 @default.
- W2892269780 cites W2293790021 @default.
- W2892269780 cites W2311850031 @default.
- W2892269780 cites W2316018428 @default.
- W2892269780 cites W2316290949 @default.
- W2892269780 cites W2319568334 @default.
- W2892269780 cites W2335076459 @default.
- W2892269780 cites W2346274463 @default.
- W2892269780 cites W2412836877 @default.
- W2892269780 cites W2416837370 @default.
- W2892269780 cites W2518844206 @default.
- W2892269780 cites W2547630647 @default.
- W2892269780 cites W2550413065 @default.
- W2892269780 cites W2553876999 @default.
- W2892269780 cites W2584977435 @default.
- W2892269780 cites W2593436234 @default.
- W2892269780 cites W2733852024 @default.
- W2892269780 cites W2766906702 @default.
- W2892269780 cites W2773480339 @default.
- W2892269780 cites W2790580737 @default.
- W2892269780 cites W2791622314 @default.
- W2892269780 cites W2793827830 @default.
- W2892269780 cites W2802937920 @default.
- W2892269780 cites W2803124976 @default.
- W2892269780 cites W2804228544 @default.
- W2892269780 cites W2805353486 @default.
- W2892269780 cites W2874157244 @default.
- W2892269780 cites W3175318380 @default.
- W2892269780 cites W787482168 @default.
- W2892269780 doi "https://doi.org/10.1016/j.ijbiomac.2018.09.001" @default.
- W2892269780 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30189275" @default.
- W2892269780 hasPublicationYear "2018" @default.
- W2892269780 type Work @default.
- W2892269780 sameAs 2892269780 @default.
- W2892269780 citedByCount "42" @default.
- W2892269780 countsByYear W28922697802019 @default.
- W2892269780 countsByYear W28922697802020 @default.
- W2892269780 countsByYear W28922697802021 @default.
- W2892269780 countsByYear W28922697802022 @default.
- W2892269780 countsByYear W28922697802023 @default.
- W2892269780 crossrefType "journal-article" @default.
- W2892269780 hasAuthorship W2892269780A5015967784 @default.
- W2892269780 hasAuthorship W2892269780A5016579839 @default.
- W2892269780 hasAuthorship W2892269780A5022825134 @default.
- W2892269780 hasAuthorship W2892269780A5035798686 @default.
- W2892269780 hasAuthorship W2892269780A5040020657 @default.
- W2892269780 hasAuthorship W2892269780A5064016293 @default.
- W2892269780 hasAuthorship W2892269780A5064488322 @default.
- W2892269780 hasAuthorship W2892269780A5070602119 @default.